Today's Veterinary Practice

JAN-FEB 2016

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: http://todaysveterinarypractice.epubxp.com/i/619503

Contents of this Issue

Navigation

Page 34 of 139

Give dogs all the Lyme protection they need and none of the antigens they don't. It only takes a single protein, OspA, to block the transmission of Borrelia burgdorferi in the United States. 1,2,3 Protect your patients with nothing less, expose them to nothing more. ®RECOMBITEK is a registered trademark of Merial. ©2015 Merial, Inc., Duluth, GA. All rights reserved. REC15NALYMEAD (05/15). 1 Straubinger RK, Chang YF, Jacobson RH, Appel MJ. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J Clin Microbiol. 1995;33(10):2745-2751. 2 Rice Conlon JA, Mather TN, Tanner P, Gallo G, Jacobson RH. Effcacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet Ther. 2000;1(2):96-107. 3 Probert WS, Crawford M, Cadiz RB, LeFebvre RB. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis. 1997;175(2):400-405. RECOMBITEK ® Lyme - the only vaccine with OspA in a nonadjuvanted formula

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Practice - JAN-FEB 2016